Proteasome Activity as a Target of Hormone Replacement Therapy–Dependent Plaque Stabilization in Postmenopausal Women
- 1 April 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 51 (4), 1135-1141
- https://doi.org/10.1161/hypertensionaha.107.105239
Abstract
The molecular mechanisms of the atheroprotective effect evoked by hormone replacement therapy in postmenopausal women is not well known. Recently, we have demonstrated enhanced activity of the ubiquitin-proteasome system in human atherosclerotic plaques and evidenced that it is associated with inflammatory-induced plaque rupture. Therefore, we hypothesized that hormone replacement therapy may exert the cardioprotective effects modulating the ubiquitin-proteasome activity. To investigate this possibility, this study examined the differences in inflammatory infiltration, as well as ubiquitin-proteasome activity, between asymptomatic carotid plaques of postmenopausal women with and without concomitant hormone replacement therapy. Plaques were obtained from 20 postmenopausal women treated with hormone replacement therapy (current users) and 32 nontreated women (never-users) enlisted to undergo carotid endarterectomy for extracranial high-grade (>70%) internal carotid artery stenosis. Plaques were analyzed for macrophages, T lymphocytes, human leukocyte antigen-DR+ cells, ubiquitin-proteasome system, nuclear factor κB, inhibitor of nuclear factor κBβ, tumor necrosis factor-α, nitrotyrosine, matrix metalloproteinase-9, and collagen content (immunohistochemistry and ELISA). Compared with plaques from current users, plaques from never-users had more macrophages, T lymphocytes, and human leukocyte antigen-DR+ cells ( P P P P <0.001). This study supports the hypothesis that hormone replacement therapy inhibits plaque ubiquitin-proteasome activity by decreasing oxidative stress generation in postmenopausal women. This effect, in turn, might contribute to plaque stabilization by inhibiting the activation of nuclear factor κB–dependent inflammation, responsible for plaque rupture.Keywords
This publication has 24 references indexed in Scilit:
- Morning Blood Pressure Surge as a Destabilizing Factor of Atherosclerotic PlaqueHypertension, 2007
- Increased Activity of the Ubiquitin-Proteasome System in Patients With Symptomatic Carotid Disease Is Associated With Enhanced Inflammation and May Destabilize the Atherosclerotic Plaque: Effects of Rosiglitazone TreatmentJournal of the American College of Cardiology, 2006
- Cytokines in Atherosclerosis: Pathogenic and Regulatory PathwaysPhysiological Reviews, 2006
- The ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extendedCardiovascular Research, 2004
- Hormone Replacement Therapy and InflammationHypertension, 2003
- Oxidative stress‐related increase in ubiquitination in early coronary atherogenesisThe FASEB Journal, 2003
- Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.JCI Insight, 1996
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994
- Estrogens inhibit copper and cell-mediated modification of low density lipoproteinAtherosclerosis, 1991
- The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activityThe Journal of Steroid Biochemistry and Molecular Biology, 1981